Regeneron: Scaling NGS to Deliver More Discoveries, Faster

April 14, 2017

Aris Baras and John Overton of Regeneron discuss their latest work and overall mission to explore new variations in genomes that can help explain disease. As one of the largest biotech companies in the world, Regeneron’s focus on large scale sequencing studies and finding mutations in certain genes is ultimately improving patient outcomes. Hear how they plan to utilize the NovaSeq™ 6000 System and why the introduction of this new technology is allowing them to redesign their experiments to take advantage of a whole new level of scale and output.

View related videos

View related webinars

View related information

Subscribe to the Illumina video channel. For Research Use Only. Not for use in diagnostic procedures. A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.

View customer spotlight videos

View Illumina webinars

View Illumina product videos

View Illumina support videos

Share this article on